Maccabi Netanya will be acquired by US firm Aliya Capital Partners, led by Ross Kestin, pending approval. The deal reflects rising foreign interest in Israeli soccer.

Regeneron Commits to Comply with Company's Privacy Policy and All Applicable Law; No Changes to 23andMe's Privacy Policy or Consumer Genome Services Transaction Subject to Court Approval SAN FRANCISCO ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.